BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38280378)

  • 1. Lineage and ecology define liver tumor evolution in response to treatment.
    Revsine M; Wang L; Forgues M; Behrens S; Craig AJ; Liu M; Tran B; Kelly M; Budhu A; Monge C; Xie C; Hernandez JM; Greten TF; Wang XW; Ma L
    Cell Rep Med; 2024 Feb; 5(2):101394. PubMed ID: 38280378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-cell atlas of tumor cell evolution in response to therapy in hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
    Ma L; Wang L; Khatib SA; Chang CW; Heinrich S; Dominguez DA; Forgues M; Candia J; Hernandez MO; Kelly M; Zhao Y; Tran B; Hernandez JM; Davis JL; Kleiner DE; Wood BJ; Greten TF; Wang XW
    J Hepatol; 2021 Dec; 75(6):1397-1408. PubMed ID: 34216724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor Cell Biodiversity Drives Microenvironmental Reprogramming in Liver Cancer.
    Ma L; Hernandez MO; Zhao Y; Mehta M; Tran B; Kelly M; Rae Z; Hernandez JM; Davis JL; Martin SP; Kleiner DE; Hewitt SM; Ylaya K; Wood BJ; Greten TF; Wang XW
    Cancer Cell; 2019 Oct; 36(4):418-430.e6. PubMed ID: 31588021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-cell transcriptomics reveals the role of Macrophage-Naïve CD4 + T cell interaction in the immunosuppressive microenvironment of primary liver carcinoma.
    Mo Z; Liu D; Chen Y; Luo J; Li W; Liu J; Yu L; Huang B; Zhang S
    J Transl Med; 2022 Oct; 20(1):466. PubMed ID: 36221095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiregional single-cell dissection of tumor and immune cells reveals stable lock-and-key features in liver cancer.
    Ma L; Heinrich S; Wang L; Keggenhoff FL; Khatib S; Forgues M; Kelly M; Hewitt SM; Saif A; Hernandez JM; Mabry D; Kloeckner R; Greten TF; Chaisaingmongkol J; Ruchirawat M; Marquardt JU; Wang XW
    Nat Commun; 2022 Dec; 13(1):7533. PubMed ID: 36476645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overweight/obesity-related transcriptomic signature as a correlate of clinical outcome, immune microenvironment, and treatment response in hepatocellular carcinoma.
    Feng NN; Du XY; Zhang YS; Jiao ZK; Wu XH; Yang BM
    Front Endocrinol (Lausanne); 2022; 13():1061091. PubMed ID: 36714595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Necroptosis microenvironment directs lineage commitment in liver cancer.
    Seehawer M; Heinzmann F; D'Artista L; Harbig J; Roux PF; Hoenicke L; Dang H; Klotz S; Robinson L; Doré G; Rozenblum N; Kang TW; Chawla R; Buch T; Vucur M; Roth M; Zuber J; Luedde T; Sipos B; Longerich T; Heikenwälder M; Wang XW; Bischof O; Zender L
    Nature; 2018 Oct; 562(7725):69-75. PubMed ID: 30209397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and validation of an angiogenesis-related scoring model to predict prognosis, tumor immune microenvironment and therapeutic response in hepatocellular carcinoma.
    Tang B; Zhang X; Yang X; Wang W; Li R; Liu Y
    Front Immunol; 2022; 13():1013248. PubMed ID: 36466855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo transcriptomic subtyping of colorectal cancer liver metastases in the context of tumor heterogeneity.
    Moosavi SH; Eide PW; Eilertsen IA; Brunsell TH; Berg KCG; Røsok BI; Brudvik KW; Bjørnbeth BA; Guren MG; Nesbakken A; Lothe RA; Sveen A
    Genome Med; 2021 Sep; 13(1):143. PubMed ID: 34470666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma.
    Zhang Q; He Y; Luo N; Patel SJ; Han Y; Gao R; Modak M; Carotta S; Haslinger C; Kind D; Peet GW; Zhong G; Lu S; Zhu W; Mao Y; Xiao M; Bergmann M; Hu X; Kerkar SP; Vogt AB; Pflanz S; Liu K; Peng J; Ren X; Zhang Z
    Cell; 2019 Oct; 179(4):829-845.e20. PubMed ID: 31675496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promising key genes associated with tumor microenvironments and prognosis of hepatocellular carcinoma.
    Pan L; Fang J; Chen MY; Zhai ST; Zhang B; Jiang ZY; Juengpanich S; Wang YF; Cai XJ
    World J Gastroenterol; 2020 Feb; 26(8):789-803. PubMed ID: 32148377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deciphering the immune modulation through deep transcriptomic profiling and therapeutic implications of DNA damage repair pattern in hepatocellular carcinoma.
    Hong W; Zhang Y; Wang S; Zheng D; Hsu S; Zhou J; Fan J; Zeng Z; Wang N; Ding Z; Yu M; Gao Q; Du S
    Cancer Lett; 2024 Feb; 582():216594. PubMed ID: 38135208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse genomic alterations and stemness features are induced by field cancerization in the microenvironment of hepatocellular carcinomas.
    Castven D; Fischer M; Becker D; Heinrich S; Andersen JB; Strand D; Sprinzl MF; Strand S; Czauderna C; Heilmann-Heimbach S; Roessler S; Weinmann A; Wörns MA; Thorgeirsson SS; Galle PR; Matter MS; Lang H; Marquardt JU
    Oncotarget; 2017 Jul; 8(30):48688-48700. PubMed ID: 28415775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative single-cell transcriptomic analyses reveal the cellular ontological and functional heterogeneities of primary and metastatic liver tumors.
    Gui M; Huang S; Li S; Chen Y; Cheng F; Liu Y; Wang JA; Wang Y; Guo R; Lu Y; Cao P; Zhou G
    J Transl Med; 2024 Feb; 22(1):206. PubMed ID: 38414027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.
    Xiang S; Li J; Shen J; Zhao Y; Wu X; Li M; Yang X; Kaboli PJ; Du F; Zheng Y; Wen Q; Cho CH; Yi T; Xiao Z
    Front Immunol; 2021; 12():653836. PubMed ID: 33897701
    [No Abstract]   [Full Text] [Related]  

  • 16. Understanding tumour cell heterogeneity and its implication for immunotherapy in liver cancer using single-cell analysis.
    Heinrich S; Craig AJ; Ma L; Heinrich B; Greten TF; Wang XW
    J Hepatol; 2021 Mar; 74(3):700-715. PubMed ID: 33271159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A scoring model based on ferroptosis genes for prognosis and immunotherapy response prediction and tumor microenvironment evaluation in liver hepatocellular carcinoma.
    Gao L; Xue J; Liu X; Cao L; Wang R; Lei L
    Aging (Albany NY); 2021 Nov; 13(22):24866-24881. PubMed ID: 34839280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revealing the role of necroptosis microenvironment: FCGBP + tumor-associated macrophages drive primary liver cancer differentiation towards cHCC-CCA or iCCA.
    Wang C; Chen C; Hu W; Tao L; Chen J
    Apoptosis; 2024 Apr; 29(3-4):460-481. PubMed ID: 38017206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reliability of a single-region sample to evaluate tumor immune microenvironment in hepatocellular carcinoma.
    Shen YC; Hsu CL; Jeng YM; Ho MC; Ho CM; Yeh CP; Yeh CY; Hsu MC; Hu RH; Cheng AL
    J Hepatol; 2020 Mar; 72(3):489-497. PubMed ID: 31634533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-cell transcriptome analysis reveals tumor immune microenvironment heterogenicity and granulocytes enrichment in colorectal cancer liver metastases.
    Zhang Y; Song J; Zhao Z; Yang M; Chen M; Liu C; Ji J; Zhu D
    Cancer Lett; 2020 Feb; 470():84-94. PubMed ID: 31610266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.